 |
|
|
| |
Impact of the COVID-19 Pandemic on Hepatitis C Virus Screening in
Drug Treatment Settings in England and Implications for Future Testing Protocols
|
| |
| |
EASL 2021 Presented at The International Liver Congress (EASL), 23-26 June 2021
S. Salehi1, T. Kemp2, H. Hampton3, S. Smith4, P. Smethurst5
1Medical Affairs, Gilead Sciences Ltd., London, United Kingdom 2Change Grow Live, Leeds, United Kingdom 3We Are With You, London, United Kingdom 4Human Kind, Manchester, United Kingdom 5Patient Access to Care, Gilead Sciences Ltd., London, United Kingdom
|
| |
|
|
|
|
|
